One - Cycle BE500P Seems Safe for High - Risk Early Testicular Cancer

Malignant recurrence rate was 1.3 percent at two years for one - cycle BE500P in high - risk early - stage disease
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Journal, Source Type: news